Skip to content

A Clinical Study on the Effects of Benzac Soap for Acne, Oil Control, and Skin Appearance

A Single Center, Open Label Clinical Study to Evaluate the Efficacy and Cosmetic Benefits of Benzac Soap (2 Percent Salicylic Acid) on Acne Lesions, Sebum Control, and Skin Appearance After Regular Use. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111942
Enrollment
30
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Benzac Soap (2% salicylic acid): Dosage form: Soap bar, Duration: 30 days, Dosage: Use twice a day for washing the face during routine cleansing Control Intervention1: NIL: NIL

Sponsors

VVF India Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy male and female participants 2. Mild to moderate acne / oily or combination skin 3. Visible facial pores and sebum 4. Willingness to comply with study requirements 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1.Severe acne or dermatological conditions requiring medical treatment 2.Use of topical/systemic acne medications within the washout period 3.Known allergy to cosmetic products or test ingredients 4.Active systemic illness or immunocompromised state 5.Pregnant or lactating women, or those planning to become pregnant 6.Participation in another clinical study within the last 30 days

Design outcomes

Primary

MeasureTime frame
1.Mean percentage change in inflammatory, non inflammatory, and total lesion count. 2.Mean change in sebum levels ( g/cm )Timepoint: Day 0 to Day 30

Secondary

MeasureTime frame
1.Improvement scores in clinical grading of skin smoothness, tone evenness, and radiance. 2.To assess the safety and tolerability of 2% salicylic acid soap in the study participants.Timepoint: Day 0 to Day 30

Countries

India

Contacts

Public ContactDr Ashok Godavarthi

Radiant Research Services Pvt Ltd

surya.ashok@gmail.com09880999297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026